{"disease":{"id":"chloasma","name":"Chloasma","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"fluocinolone-acetonide","indication_name":"Chloasma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Derma-Smoothe/Fs","generic_name":"FLUOCINOLONE ACETONIDE","company_name":"Eurofarma","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"tretinoin","indication_name":"Chloasma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Retin-A","generic_name":"TRETINOIN","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Nuclear receptor ROR-beta","drug_class":"Retinoid [EPC]","quality_score":58,"revenue":null,"mechanism":"Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation."},{"drug_id":"hydroquinone","indication_name":"Chloasma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tri-Luma","generic_name":"HYDROQUINONE","company_name":"Galderma Labs Lp","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 2","drug_class":"Melanin Synthesis Inhibitor [EPC]","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"dioxybenzone","indication_name":"Chloasma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dioxybenzon","generic_name":"DIOXYBENZONE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"metahexamide","indication_name":"Chloasma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Melanex","generic_name":"METAHEXAMIDE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"metahexamide","quality_score":null,"revenue":null,"mechanism":"Melanex works by inhibiting the enzyme tyrosinase, which is involved in the production of melanin, the pigment responsible for skin color."}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03585179","title":"Oral and Topical Tranexamic Acid for the Treatment of Melasma","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Centro Dermatológico Dr. Ladislao de la Pascua","has_results":false},{"nct_id":"NCT06418568","title":"Efficacy and Safety Trial of Using Ultra-Pulsed Shockwaves to Deliver Tranexamic Acid for the Treatment of Melasma","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03618277","title":"Identification of Biomarkers and Characterization of Melasma","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pierre Fabre Dermo Cosmetique","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}